Preferences for services in a patient’s first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study
Gates Open Research · 2024
DOI: 10.12688/gatesopenres.14682.2 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Gates Open Research, 2024. Verfasst von Mhairi Maskew und 11 weiteren Autor:innen. Beteiligte Einrichtung: Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand Johannesburg, Johannesburg, Gauteng, S…. Hauptthemen laut MEDLINE: HIV Infections. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gates Foundation, Bill and Melinda Gates Foundation.
Abstract (Originalsprache)
Background For patients on HIV treatment in sub-Saharan Africa, the highest risk for loss from care remains the first six months after antiretroviral (ART) initiation, when patients are not yet eligible for differentiated service delivery (DSD) models that offer lower-burden, patient-centred care and thus improve treatment outcomes. To reduce early disengagement from care, the PREFER study will use a sequential mixed-methods approach to describe the characteristics, needs, concerns, and preferences of patients in South Africa and Zambia 0-6 months after ART initiation or re-initiation. Protocol PREFER is an observational, prospective cohort study of adults on ART for ≤6 months at 12 public healthcare facilities in Zambia and 18 in South Africa. Its objective is to describe and understand the needs and preferences of initiating and re-initiating ART clients to inform the design of DSD models for the early HIV treatment period, improve early treatment outcomes, and distinguish the barriers encountered by naïve patients from those facing re-initiators. It has four components: 1) survey of clients 0-6 months after ART initiation (identify characteristics and preferences of clients starting ART); 2) follow up through routinely collected medical records for
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand Johannesburg, Johannesburg, Gauteng, South Africa.
- Global Health, Boston University, Boston, MA, 02118, USA.
- Department of Medical Microbiology, Amsterdam University Medical Center, Amstersdam, The Netherlands.
- CHAI-Zambia, Clinton Health Access Initiative, Lusaka, Zambia.
- MOH Zambia, Ministry of Health, Lusaka, Zambia.
- Center for Infectious Disease Research in Zambia, Lusaka, Lusaka Province, Zambia.
ORCID-Profile: Sydney Rosen
Förderung
- Gates Foundation
- Bill and Melinda Gates Foundation
Zitieren
APA
Maskew, M., Ntjikelane, V., Juntunen, A., Scott, N., Benade, M., Sande, L., Hasweeka, P., Haimbe, P., Lumano-Mulenga, P., Shakewelele, H., Mukumbwa-Mwenechanya, M., & Rosen, S. (2024). Preferences for services in a patient’s first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study. Gates Open Research. https://doi.org/10.12688/gatesopenres.14682.2
Vancouver
Maskew M, Ntjikelane V, Juntunen A, Scott N, Benade M, Sande L, et al. Preferences for services in a patient’s first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study. Gates Open Research. 2024. doi:10.12688/gatesopenres.14682.2
BibTeX
@article{Maskew2024,
author = {Maskew, Mhairi and Ntjikelane, Vinolia and Juntunen, Allison and Scott, Nancy and Benade, Mariet and Sande, Linda and Hasweeka, Pamfred and Haimbe, Prudence and Lumano-Mulenga, Priscilla and Shakewelele, Hilda and Mukumbwa-Mwenechanya, Mpande and Rosen, Sydney},
title = {Preferences for services in a patient’s first six months on antiretroviral therapy for HIV in South Africa and Zambia (PREFER): research protocol for a prospective observational cohort study},
journal = {Gates Open Research},
year = {2024},
doi = {10.12688/gatesopenres.14682.2}
}
EUVIMED